🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Ireland / NCT05986253
Active, not recruiting Not applicable

BioDulse II: The Effect of an Irish Seaweed Protein Extract on Glucose Control in Adults With Type 2 Diabetes

NCT05986253 · tracked via the Priya Life Science Ireland tracker
Sponsor
University of Limerick
Phase
Not applicable
Started
2023-08-07
Last updated
2024-04-09

Condition(s) studied

Type 2 Diabetes

Investigational drug(s) / intervention(s)

Seaweed proteinMaltodextrin

Seaweed protein: Novel protein extracted from seaweed

Maltodextrin: maltodextrin solution

Study summary

Co-ingesting protein with carbohydrate is an effective way to improve postprandial glucose handling. The investigators have isolated and identified a bioactive protein extracted from seaweed. The investigators aim to explore how varying doses of seaweed protein influence postprandial glycaemia and insulinaemia in a population with type 2 diabetes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
67 Years
Healthy volunteers
No
Inclusion Criteria: * Aged 18-67 Exclusion Criteria: * Terminal disease * Exclusively receiving enteral or parenteral nutrition * Any conditions/anomalies that are contraindications to bioelectrical impedance analysis as per institutional risk assessment and standard operating procedures * Past medical history of cancer, neurological, kidney, pulmonary, digestive (Coeliac disease), thyroidal disease, cognitive impairment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Limerick Limerick Ireland
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05986253 on ClinicalTrials.gov ↗ ← All trials in Ireland